News from the healthcare data industry
COBALT study in advanced PBC, previously terminated early due to feasibility challenges, did not demonstrate a statistically significant difference in clinical endpoints between Ocaliva® and placebo HEROES-US real-world analysis demonstrated statistically significant improvement in event-free survival in patients receiving Ocaliva for PBC Intercept plans to include these data in an evidence…
LEADER Trial Will Use Results from Foundation Medicine’s Comprehensive Genomic Profiling Tests to Screen for Actionable Driver Mutations to Inform Trial Enrollment and Targeted Therapy Options for Patients New “Trial in Progress” Abstract at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Details LEADER’s Primary Objective to Determine the…
CHICAGO, IL, UNITED STATES, June 3, 2022 /EINPresswire.com/ — Today, at the annual meeting of the American Society of Clinical Oncology (ASCO), Prognos Health and xCures announced a collaboration to enable real-world data access and insights for life science companies across multiple use cases. The multi-year agreement will enable linking…
June 03, 2022 Vancouver, BC — Genomic research is leading to incredible advances in modern-day healthcare but combining health and genomic data can greatly accelerate new discoveries. To enable the advancement of medical research and patient care, Genome British Columbia (Genome BC) has committed an investment of up to $1 million…
CHICAGO, June 2, 2022 /PRNewswire/ — EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry, and Limitless Minds™, a business and wellness coaching firm founded by professional athlete Russell Wilson and co-founders Trevor Moawad, Harrison Wilson, and DJ Eidson, announced the launch of an integrated learning and performance solution for life sciences professionals. The new offering is…
June 02, 2022 06:59 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE:PLTR) announced today that the U.S. Space Systems Command (SSC) Battle Management Command, Control, and Communications (BMC3) awarded Palantir a $53,899,333.40 increase on May 24, 2022, to its 2021 award of $121,500,000.00. This increase brings the total value…
By Brittany Wade June 2, 2022 | Innovation Practices Award–Extracting high-quality data from clinical records can be time-consuming and costly, primarily when manual abstractors are tasked with mining complex, unstructured, and lengthy documents. Not to mention, word choice, format, and symptom documentation vary among healthcare settings. This arduous process lead the…
Members of CDRC will be able to utilize xCures’ technology to quickly abstract and structure clinical data to support drug repurposing studies in rare cancer. This partnership will enable CDRC members researching rare cancers to access state-of-the-art tools to facilitate clinical evidence generation using real-world data.” — Marco Schito, Ph.D.,…
Real-world results may differ from clinical trial results for some drugs approved to treat gastrointestinal cancers, according to research published in Clinical Oncology. Researchers found that EGFR inhibitors and sorafenib performed as expected in the real world, but some chemotherapy drugs did not. For this study, researchers used the Systemic Anti-Cancer…
Austin, Texas—June 1, 2022 Today, Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better…